Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury
- 1 October 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 314 (1-2) , 99-107
- https://doi.org/10.1016/s0014-2999(96)00549-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Non-uniform recovery of segment shortening during reperfusion following regional myocardial ischaemia despite uniform recovery of ATPCardiovascular Research, 1995
- Cardioprotective effects of carvedilol, a novel adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranololCardiovascular Research, 1992
- Compensatory subendocardial hyperkinesis in the cat is abolished during coronary insufficiency outside an acutely ischaemic regionCardiovascular Research, 1992
- Myocardial Protection with CarvedilolJournal of Cardiovascular Pharmacology, 1992
- Oxygen-derived free radicals and myocardial reperfusion injury: An overviewCardiovascular Drugs and Therapy, 1991
- Carvedilol (Kredex®) Reduces Infarct Size in a Canine Model of Acute Myocardial InfarctionPharmacology, 1991
- Mechanism of myocardial "stunning".Circulation, 1990
- Can superoxide dismutase alter myocardial infarct size?Circulation, 1989
- Myocardial consequences of reperfusionProgress in Cardiovascular Diseases, 1987
- A critical look at currently used indirect indices of myocardial oxygen consumptionBasic Research in Cardiology, 1981